Compliance Rate
Compliance Rate
33.33%
Compliant submissions
1
Incompliant submissions
2
Total trials
3
My Organizations' Clinical Trials
Showing 700 of 788 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/30/05
End: 06/30/08
Due: 06/30/09
Phase: N/A
Priority: Normal
Start: 12/31/14
End: 11/21/17
Due: 11/21/18
Phase: N/A
Priority: Normal
Start: 02/22/19
End: 03/19/21
Due: 03/19/22
Phase: N/A
Priority: Normal
Start: 04/01/25
End: 09/30/26
Due: 09/30/27
Phase: N/A
Priority: Normal
Start: 05/01/25
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 04/15/19
End: 02/01/24
Due: 02/01/25
Phase: N/A
Priority: Normal
Start: 11/06/23
End: 11/30/25
Due: 11/30/26
Phase: N/A
Priority: Normal
Start: 12/31/07
End: 01/31/10
Due: 01/31/11
Phase: N/A
Priority: Normal
Start: 09/30/09
End: 07/31/11
Due: 07/31/12
Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma Multiforme
Phase: N/A
Priority: Normal
Start: 07/31/12
End: 09/30/14
Due: 09/30/15
Phase: N/A
Priority: Normal
Start: 10/13/17
End: 12/12/23
Due: 12/12/24
Phase: N/A
Priority: Normal
Start: 05/01/25
End: 05/01/28
Due: 05/01/29
Phase: N/A
Priority: Normal
Start: 02/09/16
End: 06/14/18
Due: 06/14/19
Phase: N/A
Priority: Normal
Start: 08/31/07
End: 06/30/09
Due: 06/30/10
Phase: N/A
Priority: Normal
Start: 09/30/07
End: 08/31/12
Due: 08/31/13
Phase: N/A
Priority: Normal
Start: 07/01/24
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 09/17/19
End: 01/01/55
Due: 01/01/56
Phase: N/A
Priority: Normal
Start: 10/31/12
End: 11/30/13
Due: 11/30/14
Phase: N/A
Priority: Normal
Start: 03/31/13
End: 03/31/13
Due: 03/31/14
Phase: N/A
Priority: Normal
Start: 07/10/25
End: 04/01/30
Due: 04/01/31
Phase: N/A
Priority: Normal
Start: 07/01/25
End: 08/31/28
Due: 08/31/29
Phase: N/A
Priority: Normal
Start: 11/18/18
End: 02/21/26
Due: 02/21/27
Phase: N/A
Priority: Normal
Start: 02/28/09
End: 07/31/10
Due: 07/31/11
Phase: N/A
Priority: Normal
Start: 04/27/17
End: 10/25/18
Due: 10/25/19
Phase: N/A
Priority: Normal
Start: 08/16/21
End: 01/19/24
Due: 01/19/25